McMaster and partners receive $2 million to help achieve UN Sustainable Development Goals

The McMaster Health Forum and 13 international partners have received a $2 million grant to help policymakers meet the UN's Sustainable Development Goals.

January 9, 2019

Image courtesy of SDG Permissions

The McMaster Health Forum and its partners in 13 countries have received a $2 million grant, equally funded by the Hewlett Foundation and Canada’s International Development Research Centre, to better support policymakers in their efforts to achieve the United Nations’ Sustainable Development Goals (SDGs).

While evidence-informed policymaking approaches, like those pioneered at the Forum and in Forum-supported networks like EVIPNet, have helped drive the strengthening of many health systems around the world, the new Partners for Evidence-driven Rapid Learning in Social Systems (PERLSS) will adapt, pilot and iteratively refine these approaches in the broader social-systems space and with a particular focus on the SDGs.

“The SDGs are an ambitious agenda, aiming to improve global outcomes across a range of social and economic development issues,” said John Lavis, Director of the McMaster Health Forum and Forum+. “We’re hoping to help support the achievement of the non-health SDGs using best evidence, citizen values and stakeholder insights.”

The objectives of the PERLSS network are to: 1) pilot and refine mechanisms to: support evidence-informed policymaking about social systems and the Sustainable Development Goals; 2) strengthen target organizations’ institutional capacities and join up model examples of policy-supporting organizations, and build a community of practice to support institutional lesson-learning across contexts and issues.

“We look forward to working with our partners to build capacity and demand for evidence-informed policymaking,” said Lavis.

Learn more about this new international network.

Three scientists standing together in a laboratory. Two are holding small bottles.

New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data shows

The findings point to a potential new treatment for millions of people, addressing a critical gap where no approved drugs exist in Canada.
A smiling person in the background, with their hand holding a vial of medicine in the foreground.

‘Helper molecule’ discovery offers new hope against drug-resistant fungal infections

Postdoc’s painstaking sleuthing yields the Wright Lab’s third groundbreaking antimicrobial discovery in a year.
Two smiling people working at a computer in a lab. One is wearing a lab coat.

How McMaster is advancing healthy aging through research, partnerships and impact

‘Aging doesn’t happen in silos.’ At the McMaster Institute for Research on Aging, researchers from all faculties work together to study the complex, interconnected factors affecting how we age.